Literature DB >> 10958674

Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression.

S K Oster1, W W Marhin, C Asker, L M Facchini, P A Dion, K Funa, M Post, J M Sedivy, L Z Penn.   

Abstract

Platelet-derived growth factor BB (PDGF BB) is a potent mitogen for fibroblasts as well as many other cell types. Interaction of PDGF BB with the PDGF beta receptor (PDGF-betaR) activates numerous signaling pathways and leads to a decrease in receptor expression on the cell surface. PDGF-betaR downregulation is effected at two levels, the immediate internalization of ligand-receptor complexes and the reduction in pdgf-betar mRNA expression. Our studies show that pdgf-betar mRNA suppression is regulated by the c-myc proto-oncogene. Both constitutive and inducible ectopic Myc protein can suppress pdgf-betar mRNA and protein. Suppression of pdgf-betar mRNA in response to Myc is specific, since expression of the related receptor pdgf-alphar is not affected. We further show that Myc suppresses pdgf-betar mRNA expression by a mechanism which is distinguishable from Myc autosuppression. Analysis of c-Myc-null fibroblasts demonstrates that Myc is required for the repression of pdgf-betar mRNA expression in quiescent fibroblasts following mitogen stimulation. In addition, it is evident that the Myc-mediated repression of pdgf-betar mRNA levels plays an important role in the regulation of basal pdgf-betar expression in proliferating cells. Thus, our studies suggest an essential role for Myc in a negative-feedback loop regulating the expression of the PDGF-betaR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10958674      PMCID: PMC86202          DOI: 10.1128/MCB.20.18.6768-6778.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

Review 1.  Mechanism of action of platelet-derived growth factor.

Authors:  L Claesson-Welsh
Journal:  Int J Biochem Cell Biol       Date:  1996-04       Impact factor: 5.085

2.  An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants.

Authors:  R J Miltenberger; K A Sukow; P J Farnham
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

3.  Reduction in platelet-derived growth factor receptor mRNA in v-src-transformed fibroblasts.

Authors:  Q X Zhang; F Walker; A W Burgess; G S Baldwin
Journal:  Biochim Biophys Acta       Date:  1995-04-06

4.  Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts.

Authors:  C Vaziri; D V Faller
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

5.  Cdc25 cell-cycle phosphatase as a target of c-myc.

Authors:  K Galaktionov; X Chen; D Beach
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

6.  Dysfunction of the Myc-induced apoptosis mechanism accompanies c-myc activation in the tumorigenic L929 cell line.

Authors:  L M Facchini; S Chen; L J Penn
Journal:  Cell Growth Differ       Date:  1994-06

7.  Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop.

Authors:  A Guha; K Dashner; P M Black; J A Wagner; C D Stiles
Journal:  Int J Cancer       Date:  1995-01-17       Impact factor: 7.396

8.  An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation.

Authors:  D E Brough; T J Hofmann; K B Ellwood; R A Townley; M D Cole
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

9.  Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle.

Authors:  J I Daksis; R Y Lu; L M Facchini; W W Marhin; L J Penn
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

10.  c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.

Authors:  L H Li; C Nerlov; G Prendergast; D MacGregor; E B Ziff
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

View more
  13 in total

1.  Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing.

Authors:  Olivera Stojadinovic; Harold Brem; Constantinos Vouthounis; Brian Lee; John Fallon; Michael Stallcup; Ankit Merchant; Robert D Galiano; Marjana Tomic-Canic
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

Review 2.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 3.  Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.

Authors:  Akinfemi Ayobami Akingboye; Stephen Giddins; Philip Gamston; Arthur Tucker; Harshad Navsaria; Constantions Kyriakides
Journal:  J Extra Corpor Technol       Date:  2010-03

4.  Myc potentiates apoptosis by stimulating Bax activity at the mitochondria.

Authors:  E L Soucie; M G Annis; J Sedivy; J Filmus; B Leber; D W Andrews; L Z Penn
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation.

Authors:  Qi Yang; William W Du; Nan Wu; Weining Yang; Faryal Mehwish Awan; Ling Fang; Jian Ma; Xiangmin Li; Yan Zeng; Zhenguo Yang; Jun Dong; Azam Khorshidi; Burton B Yang
Journal:  Cell Death Differ       Date:  2017-06-16       Impact factor: 15.828

6.  p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.

Authors:  Ryan C Widau; Yanbin Zheng; Caroline Y Sung; Anna Zelivianskaia; Lauren E Roach; Karen M Bachmeyer; Tatiana Abramova; Aurelie Desgardin; Andrew Rosner; John M Cunningham; Stephen X Skapek
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

7.  Promoter-binding and repression of PDGFRB by c-Myc are separable activities.

Authors:  Daniel Y L Mao; Dalia Barsyte-Lovejoy; Cynthia S W Ho; John D Watson; Angelina Stojanova; Linda Z Penn
Journal:  Nucleic Acids Res       Date:  2004-06-29       Impact factor: 16.971

Review 8.  Assessing adaptation of the cancer kinome in response to targeted therapies.

Authors:  Jon S Zawistowski; Lee M Graves; Gary L Johnson
Journal:  Biochem Soc Trans       Date:  2014-08       Impact factor: 5.407

9.  Sp1 is a key regulator of the PDGF beta-receptor transcription.

Authors:  C Molander; A Hackzell; M Ohta; H Izumi; K Funa
Journal:  Mol Biol Rep       Date:  2001       Impact factor: 2.316

10.  Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.

Authors:  James S Duncan; Martin C Whittle; Kazuhiro Nakamura; Amy N Abell; Alicia A Midland; Jon S Zawistowski; Nancy L Johnson; Deborah A Granger; Nicole Vincent Jordan; David B Darr; Jerry Usary; Pei-Fen Kuan; David M Smalley; Ben Major; Xiaping He; Katherine A Hoadley; Bing Zhou; Norman E Sharpless; Charles M Perou; William Y Kim; Shawn M Gomez; Xin Chen; Jian Jin; Stephen V Frye; H Shelton Earp; Lee M Graves; Gary L Johnson
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.